Related Experiment Video
Updated: Mar 3, 2026

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
Published on: September 17, 2021
Vasospastic myocardial infarction caused by a slimming agent-do not forget non-prescription drugs
Mohammed Omer Anwar1, Neil Bodagh2, Mohammed Husnain Iqbal1
1Barts and the London School of Medicine and Dentistry, London, UK.
Abstract:
A 41-year-old woman presented with central chest discomfort. She had been previously well, was an ex-smoker and reported no regular medication. The ECG developed T-wave changes inferiorly and anterolaterally and troponin I concentrations were elevated confirming non-ST elevation myocardial infarction. Cardiac catheterization showed severe spasm of the right and left anterior descending coronary arteries which resolved with intracoronary nitrates. She later volunteered that prior to presentation she had been taking non-prescription Acti-Phen a slimming agent containing phentermine. Acti-Phen had its licence withdrawn in 2001 because of cardiovascular side effects including coronary spasm. Accordingly, she was advised to avoid Acti-Phen in future. The case emphasizes the importance of obtaining a complete drug history, including non-prescription drugs, in patients presenting with acute coronary syndromes.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antihypertensive Drugs: Vasodilators
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management

